1719.7000 -0.50 (-0.03%)
NSE Dec 31, 2025 15:44 PM
Volume: 1.4M
 

1719.70
-0.03%
Emkay
Sun’s 2QFY26 EBITDA was ahead of the street and our estimates (by ~12%), on the back of a marginally higher gross margin and lower R&D spend.
Sun Pharmaceutical Industries Ltd. is trading below its 30 day SMA of 1779.4
More from Sun Pharmaceutical Industries Ltd.
Recommended